Table 3 Open in new tab Outcome...

Table 3

Outcome parameters

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
ICU^∗ stay			(deceased)
Length of stay (days)	12	16	18(*)	27	18	14	17.5 ± 5.2
# days PPV	9	12	18	10	3	12	10.7 ± 4.8
Impella
Device failure	No	No	No	No	No	No	0%
Bleeding
Oozing insertion site ICU-stay	Yes	No	No	Yes	Yes	Yes	66%
BARC 3	No	No	No	Yes ENT	Yes ENT	Yes ENT	50%
Mean pfHb (g/L)	< 0.3	< 0.3	Icteric	3.54	4.86	4.4	Normal range < 5 g/L
Survived to discharge	Yes	Yes	No	Yes	Yes	Yes	83%
Non-ischaemic	Yes	Yes	No	—	Yes	—	75%
Ischaemic	—	—	—	Yes	—	Yes	100%
LVAD upgrade	No	No	No	No	No	No	0%
Residual MR	Mild	Mild	Absent	Mild	Mild	Mild
6-month survival after discharge	Yes	Yes	—	Yes	Yes	Yes	100%
Readmission for HF past 6 months	Yes	Yes	—	No	No	No	33%

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
ICU^∗ stay			(deceased)
Length of stay (days)	12	16	18(*)	27	18	14	17.5 ± 5.2
# days PPV	9	12	18	10	3	12	10.7 ± 4.8
Impella
Device failure	No	No	No	No	No	No	0%
Bleeding
Oozing insertion site ICU-stay	Yes	No	No	Yes	Yes	Yes	66%
BARC 3	No	No	No	Yes ENT	Yes ENT	Yes ENT	50%
Mean pfHb (g/L)	< 0.3	< 0.3	Icteric	3.54	4.86	4.4	Normal range < 5 g/L
Survived to discharge	Yes	Yes	No	Yes	Yes	Yes	83%
Non-ischaemic	Yes	Yes	No	—	Yes	—	75%
Ischaemic	—	—	—	Yes	—	Yes	100%
LVAD upgrade	No	No	No	No	No	No	0%
Residual MR	Mild	Mild	Absent	Mild	Mild	Mild
6-month survival after discharge	Yes	Yes	—	Yes	Yes	Yes	100%
Readmission for HF past 6 months	Yes	Yes	—	No	No	No	33%

(*) 10 days stay at ICU with positive pressure ventilation before referred for escalation of therapy. Plus-minus values indicate mean ± standard deviation.

BARC, Bleeding Academic Research Consortium; ENT, ear, nose, throat area; ICU, intensive care unit; LVAD, left ventricular assist device (long term); MR, mitral regurgitation; pfHb, plasma free haemoglobin; PPV, positive pressure ventilation.

This Feature Is Available To Subscribers Only